Icon
+91 94997 68112
Login Register

PEMFEXY - (500mg/20ml (25mg/ml); Solution, Intravenous)

PEMETREXED Eagle
500mg/20ml (25mg/ml); Solution, Intravenous
More Than $1000 mn
Less Than 5
Less Than 5
None None
None None
PEMFEXY is a folate analog metabolic inhibitor indicated for the initial treatment of patients with locally advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC)
Yes
*******,** * ******* *********** ** ******® *** ********** ***-******** ***-***** **** **** ****** *** ********* ******* ************. ***** **** ****** ******* **** *** ****. ****** **** *********** ***** *** ***(*)(*) *** ***** ***** ********** ******* ******. (*********)
PEMFEXY Patent 1 Patent 2
****** ******** *** ********* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** ******** [***(*)*] ** ******* **** ****** **** ********
  1. *** **, **** : *** ***** ***** * **** ******* ****** ******** ** ****** ******** ***** **** ** **** ******* '***.
  2. *** **, **** : *** ***** *** ****** ******** ******* ********** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.